GNLX Genelux Corporation

NASDAQ
$2.56

Genelux Corporation (GNLX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus GNLX's own trailing one-year pace, with 13% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
13 transactions
Purchases
$0
0 shares
Sales
$237.3K
85,202 shares
Net activity
-$237.3K
purchases less sales

How much of that selling was preplanned? 13% planned / 87% discretionary

10b5-1 plan sales $29.8K 1 transaction · 10,000 shares
Discretionary sales $207.5K 12 transactions · 75,202 shares

Largest single sale: $91.9K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Zindrick Thomas President and CEO Sell 34,463 $2.67 $91.9K 1,226,427 −2.7% of holding
Cappello Joseph Chief Technical Officer Sell 10,257 $2.74 $28.1K 318,480 −3.1% of holding
Yu Yong Chief Scientific Officer Sell 9,683 $2.75 $26.7K 258,688 −3.6% of holding
Zindrick Thomas President and CEO Sell 3,023 $2.95 $8.9K 1,260,890 −0.2% of holding
Cappello Joseph Chief Technical Officer Sell 653 $2.95 $1.9K 328,737 −0.2% of holding
Yu Yong Chief Scientific Officer Sell 653 $2.94 $1.9K 268,371 −0.2% of holding
Smither John W Director Sell 12,000 $2.91 $34.9K 91,403 −11.6% of holding
Smalling Ralph Head of Regulatory Sell 192 $2.93 $563 67,611 −0.3% of holding
Thomas John Director Sell 10b5-1 10,000 $2.98 $29.8K 472,784 −2.1% of holding
Zindrick Thomas President and CEO Sell 2,798 $2.94 $8.2K 532,051 −0.5% of holding
Cappello Joseph Chief Technical Officer Sell 605 $2.97 $1.8K 154,549 −0.4% of holding
Yu Yong Chief Scientific Officer Sell 605 $2.97 $1.8K 149,706 −0.4% of holding
Smalling Ralph Head of Regulatory Sell 270 $2.98 $804 67,803 −0.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.